Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic.

Annane D, Antona M, Lehmann B, Kedzia C, Chevret S; CORTIFLU Investigators; CRICs; AZUREA; REVA/SRLF networks.

Intensive Care Med. 2012 Jan;38(1):29-39. doi: 10.1007/s00134-011-2409-8. Epub 2011 Nov 26.

PMID:
22120766
2.

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.

Yazdanpanah Y, Fagard C, Descamps D, Taburet AM, Colin C, Roquebert B, Katlama C, Pialoux G, Jacomet C, Piketty C, Bollens D, Molina JM, ChĂȘne G; ANRS 139 TRIO Trial Group.

Clin Infect Dis. 2009 Nov 1;49(9):1441-9. doi: 10.1086/630210.

3.

In vitro acute effects of tobacco smoke on tumor necrosis factor alpha and interleukin-6 production by alveolar macrophages.

Dubar V, Gosset P, Aerts C, Voisin C, Wallaert B, Tonnel AB.

Exp Lung Res. 1993 May-Jun;19(3):345-59.

PMID:
8319604
4.

[In vivo kinetics of cotrimoxazole in alveolar macrophages].

Lopez I, Dubar V, Aerts C, Lhermitte M, Voisin C, Wallaert B.

Rev Mal Respir. 1991;8(1):89-94. French.

PMID:
2034860
5.

The penetration of co-trimoxazole into alveolar macrophages and its effect on inflammatory and immunoregulatory functions.

Dubar V, Lopez I, Gosset P, Aerts C, Voisin C, Wallaert B.

J Antimicrob Chemother. 1990 Dec;26(6):791-802.

PMID:
1964447
6.

[Study of the in vivo penetration of cotrimoxazole in alveolar macrophages].

Lopez I, Dubar V, Aerts C, Voisin C, Wallaert B.

Pathol Biol (Paris). 1990 Apr;38(4):286-8. French.

PMID:
2377389
Items per page

Supplemental Content

Loading ...
Write to the Help Desk